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Abstract 
The cyclin-dependent kinase inhibitor p21WAF1/Cip1 is the prototype downstream 
effector of the tumor suppressor protein p53. Yet, evidence from human cancer and 
mice models, imply that p21WAF1/Cip1, under certain conditions, can exercise 
oncogenic activity. The mechanism behind this behavior is still obscure. Within this 
context we unexpectedly noticed, predominantly in p53 mutant human cancers, that a 
subset of highly atypical cancerous cells expressing strongly p21WAF1/Cip1 
demonstrated also signs of proliferation. This finding suggests either tolerance to high 
p21WAF1/Cip1 levels or that p21WAF1/Cip1 per se guided a selective process that led to 
more aggressive off-springs. To address the latter scenario we employed p21WAF1/Cip1-
inducible p53-null cellular models and monitored them over a prolonged time period, 
using high-throughput screening means. After an initial phase characterized by stalled 
growth, mainly due to senescence, a subpopulation of p21WAF1/Cip1 cells emerged, 
demonstrating increased genomic instability, aggressiveness and chemo-resistance. At 
the mechanistic level unremitted p21WAF1/Cip1 production “saturates” the CRL4CDT2 
and SCFSkp2 ubiquitin ligase complexes reducing the turn-over of the replication 
licensing machinery. Deregulation of replication licensing triggered replication stress 
fuelling genomic instability. Conceptually, the above notion should be considered 
when anti-tumor strategies are designed, since p21WAF1/Cip1 responds also to p53-
independent signals, including various chemotherapeutic compounds. 
 
 
 
Introduction 
Accruing evidence point out that a number of molecules involved in key cellular 
processes display bimodality in cancer i.e. they can act either as tumor suppressors or 
as oncoproteins (Supplemental Table 1). This odd phenomenon is attributed to the so 
called “cellular or environmental context” that configures their behavior. The 
mechanistic basis underlying this context-dependent duality is vague in most cases 
and its explication is essential for rationally designed therapeutic strategies. 
The cyclin-dependent kinase inhibitor (CDKI) p21WAF1/Cip1 is a pivotal 
downstream effector of the master tumor-suppressor protein p53, mediating mainly 
G1 growth arrest in response to various stimuli. This function is primarily dependent 
on the ability of p21WAF1/Cip1 to inhibit cyclin-dependent kinase-2 (Cdk2)(Abbas and 
Dutta 2009). In spite of its profound p53-dependent role in halting cellular 
proliferation, several reports, in human cancer and mice models, suggest that 
p21WAF1/Cip1 can manifest oncogenic activities (Supplemental Table 1). In some of 
these studies the oncogenic function was credited to the non-conventional cytoplasmic 
localization of p21WAF1/Cip1 which binds and inhibits the activity of proteins directly 
involved in apoptosis (Roninson 2002; Pateras et al. 2009). However, in most cases 
the underlying mechanism remains speculative. It is also interesting that while p53 is 
frequently mutated in cancer (Rivlin et al. 2011), p21WAF1/Cip1 is rarely affected 
genetically (Abbas and Dutta 2009; Warfel and El-Deiry 2013). The latter would 
be logical if p21WAF1/Cip1 operated exclusively within the p53 signaling cascade. 
Nevertheless, p21WAF1/Cip1 is activated by a wide range of p53-independent signals 
and stimuli, including growth factors, nuclear receptors, chemicals and drugs (Abbas 
and Dutta 2009)(Supplemental Fig. S1).  
We report that constitutive expression of p21WAF1/Cip1, in a p53 loss of function 
environment, causes replication stress and triggers genomic instability by deregulating 
the replication licensing machinery. Replication licensing is a fundamental biological 
process that assures that replication takes place once per cell cycle (Abbas et al. 
2013). The replication licensing factors (RLFs) ORC, Cdt1 and Cdc6 accumulate 
during late M and G1 phases forming together with the MCM2-7 helicase the pre-
replication complex, licensing the genome for replication. Upon entry into S-phase 
Cdk activity increases, the replication origins are fired initiating the replication 
process, while the RLFs are targeted for degradation (unlicensed state) (Takeda and 
Dutta 2005). Deregulation of the replication licensing process is linked with genomic 
instability and promotion of malignant behavior, mainly via a process termed re-
replication (Blow and Gillespie 2008; Negrini et al. 2010; Halazonetis et al. 2008). 
Aberrant expression of RLFs is reported in various common malignancies such as 
head and neck, lung and colon cancer (Karakaidos et al. 2004; Liontos et al. 2007). 
 
 
 
 
 
 
 
Results 
1. In advanced stage cancer, a subset of atypical cells expressing p21WAF1/Cip1 
demonstrated signs of proliferation: In an array of tumors, that have not undergone 
previous chemo- or radio-therapy, we observed an unusual relationship between 
p21WAF1/Cip1 and the proliferation marker Ki67 that drove our attention. While the 
anticipated mutual exclusive p21WAF1/Cip1/Ki67 expression pattern was evident, in line 
with p21WAF1/Cip1’s growth inhibitory properties, we noticed that a number of large 
cancerous cells with giant nuclei co-expressed p21WAF1/Cip1 and Ki67 (Fig. 1). In 
pathology, identification of cancerous cells with such morphological features is 
considered a sign of adverse prognosis (Rosai and Ackerman 2011). Notably, most 
of the carcinomas examined displayed p53 alteration (Karakaidos et al. 2004; 
Liontos et al. 2007; Velimezi et al. 2013). The irregular p21WAF1/Cip1/Ki67 co-
localization led us to hypothesize either tolerance to high p21WAF1/Cip1 levels or that 
somehow constitutive p21WAF1/Cip1 expression guided a selective process resulting in 
the emergence of a subpopulation of p21WAF1/Cip1 expressing cancerous cells that 
regained their proliferative capacity and possibly during this process became more 
aggressive. 
 
2. p53-independent stimulation of p21WAF1/Cip1 up-regulates key replication 
licensing factors: To address the later scenario we employed a doxycycline-inducible 
p21WAF1/Cip1 expression system (Tet-ON) introduced in the p53 null cells Saos2 (Tet-
ON p21WAF1/Cip1 Saos2)(Bates et al, 1998) and monitored, subsequent to p21WAF1/Cip1 
induction, their behavior over a prolonged period (Supplemental Fig. S2). To avoid 
heterogeneous p21WAF1/Cip1 expression from bulk cultures we isolated p21WAF1/Cip1-
inducible clones and experimented with those demonstrating the strongest induction. 
Periodically (every 5 days) p21WAF1/Cip1 expression was evaluated by in situ analysis. 
In parallel, the transcriptome and proteome landscapes were examined at distinct 
time-points (12hs, 48hs and 96hs) in an attempt to unravel pathways/networks that 
could exercise over time an “oncogenic” effect (Supplemental Tables 2,3). 
Representative results obtained by the high-throughput assays were confirmed 
independently by quantitative real-time PCR and immune-blotting (Fig. 2, 
Supplemental Fig. S3). 
As expected and previously reported (Bates et al. 1998), the cells reduced their 
growth rate and progressively most of them acquired a senescent phenotype that 
peaked around day 10 (Supplemental Fig. S4, Supplemental Video 1). In 
accordance with the phenotypical changes and growth kinetics, two-way Gene-
Ontology biological-process enrichment analyses, followed by false discovery rate 
correction (Supplemental Fig. S2), revealed at the transcriptomic and proteomic 
level, suppression of central factors involved in “mitosis” and “mitosis surveillance” 
(Fig. 2a). Surprisingly, however, proteome analysis disclosed also a prominent up-
regulation of the RLFs, Cdt1, Cdc6 and ORC (p=1.5 x 10-6); with Cdt1 protein raise 
being the earliest biochemical alteration among all measured transcriptome and 
proteome changes (Supplemental Tables 2,3). The protein abundance raise of the 
RLFs, was not accompanied by a significant mRNA increase, implying regulation at 
the post-transcriptional level (Fig. 2). Since Cdt1 and p21WAF1/Cip1 are targeted for 
degradation by the same ubiquitin ligase complexes, CRL4CDT2 and SCFSkp2 (Abbas 
et al. 2008; Kim et al. 2008; Havens and Walter 2011), we reasoned that unremitted 
p21WAF1/Cip1 production could sequester their enzymatic activity leading eventually to 
Cdt1 accumulation (Supplemental Fig. S5a). In support to this notion, SET8, an H4 
methyltrasferase required for chromosome compaction in mitosis, and E2F1, targets 
of CRL4CDT2 (Jorgensen et al. 2011) and Skp2 (Marti et al. 1999), respectively, 
were up-regulated after p21WAF1/Cip1 induction (Supplemental Fig. S5a,S6). 
Moreover, transfection with a mutant p21WAF1/Cip1 that harbors three substitutions in 
its PIP degron motif abrogating its interaction with PCNA, which is essential for 
CRL4CDT2 to target p21WAF1/Cip1, did not augment Cdt1 expression, strongly favoring 
the “saturation/competition” mechanism (Fig. 2b). In addition, the cell cycle profile 
imposed by constitutive p21WAF1/Cip1 expression, characterized by a G1-phase increase 
and an S-phase decline, could contribute to the reduced RLF protein turn-over 
observed (Supplemental Fig. S5b). Along the same line, blocking protein synthesis 
with cyclohexamide, demonstrated a dramatic enhancement of Cdc6 protein stability, 
in p21WAF1/Cip1 expressing cells (Supplemental Fig. S5c). Reduced Cdc6 protein turn-
over could be attributed to low activity of the E3-ligase APCCdh1 that targets Cdc6 for 
degradation (Duursma and Agami 2005). Indeed, the levels of the E3-ligase APC 
substrate recognition and activating modules Cdh1/Fzr1 were decreased, supporting 
the above assumption (Supplemental Fig. S5c). Increased Cdc6 stability was also 
associated with Cdk2-mediated phosphorylation at Serine 54 (Cdc6-pS54) that 
protects it, as previously reported, from rapid destruction (Supplemental Fig. S5c) 
(Duursma and Agami 2005). Despite the fact that p21WAF1/Cip1 expression reduced 
Cdk2 activity (Supplemental Fig. S7) low Cdh1/Fzr1 levels appears to tilt the 
balance in favor of Cdc6-pS54 accumulation (Supplemental Fig. S5c). Notably, in 
the presence of cycloheximide and the proteasome inhibitor MG132, the protein 
levels of Cdh1/Fzr1 were not restored implying regulation at the transcriptional level. 
To this end we examined the mRNA levels of Cdh1/Fzr1 and found them suppressed 
under conditions of p21WAF1/Cip1 expression (Supplemental Fig. S5d). 
Since the p53 checkpoint was shown to protect from re-replication (Vaziri et al. 
2003), we reasoned that the status of p53 would define the ability of p21WAF1/Cip1 to 
regulate the levels of Cdt1 and Cdc6. Indeed, challenging cellular systems bearing 
inactive p53, with p21WAF1/Cip1, resulted in the up-regulation of these replication 
licensing factors (Fig. 2c). On the other hand, p21WAF1/Cip1 expression in a cellular 
environment with wild-type p53 suppressed their expression (Fig. 2c,d). It was 
suggested, but not shown, that p53 shields the organism from cells undergoing re-
replication by triggering apoptosis (Vaziri et al. 2003). In line with this notion, we 
noticed that the p21WAF1/Cip1-IPTG-ON HT1080 cells, harboring wtp53, experience 
massive apoptosis, after p21WAF1/Cip1 induction, which was accompanied by a 
dramatic decrease of Cdt1 and Cdc6 expression, whereas silencing of p53 suppressed 
apoptosis, up-regulated Cdt1, and restored Cdc6 levels (Vaziri et al. 2003). 
 
3. Activation of p21WAF1/Cip1, in p53 null cells, triggers replication stress in a 
Cdt1/Cdc6-dependent manner: Re-replication, is a form of replication stress and is 
considered, as mentioned, the basis of genomic instability driven by inappropriate 
expression of the RLFs, Cdc6 and Cdt1 (Blow and Gillespie 2008; Abbas et al. 
2013). Although various mechanistic aspects of how re-replication challenges the 
stability of the genome are still obscure, it is well ascertained that it leads to DNA 
damage and DNA damage response (DDR) activation (Blow and Gillespie 2008; 
Abbas et al. 2013). Following p21WAF1/Cip1 induction, MCM2-7 chromatin loading 
increased robustly indicating that Cdt1 and Cdc6 up-regulation is functional 
(Supplemental Fig. S8). Flow cytometric analysis of propidium iodide stained cells 
(DNA content) and double co-stained cells for DNA content and DNA synthesis 
(Ethynyl-deoxyUridine: EdU) revealed a cellular sub-population with DNA content 
greater than 4n, indicative of re-replication (Fig. 2e; Supplemental Video 2). 
Subsequently, DNA damage, as assessed by single cell gel electrophoresis (comet 
assay) under alkaline conditions (total number of DNA lesions) and pulse field gel 
electrophoresis (PFGE), was evident, tracked by signs of DDR, as depicted by 
increase recruitment of 53BP1 in foci and H2AX phosphorylation (γ-H2AX) (Fig. 
3a,b,c, Supplemental Fig. S6). Strikingly, re-replication, DNA damage, as well as 
the DDR, were Cdc6- and Cdt1-dependent further suggesting that re-replication was 
the source of replication stress (Fig. 3b,c). Finally, re-replication and DNA damage 
was significantly lesser when the p21PCNA mutant was employed keeping in line with 
the proposed “saturation/competition” mechanism (Supplemental Fig. S5,S9). 
It seems paradoxical that p21WAF1/Cip1 could trigger replication stress, given its 
role as a potent inhibitor of cell cycle progression. Nevertheless, fork progression 
analysis by DNA fiber spreading (DNA combing), using 20 min consecutive labeling 
pulses of CldU (red) and IdU (green), showed that replication fork progression did not 
cease, but its speed was significantly reduced (Fig. 3d). In addition, replication fork 
asymmetry was observed possibly related with the presence of DNA lesions impeding 
symmetrical bi-directional movement (Fig. 3d). Consistent with this notion, flow 
cytometry analysis with double co-staining for γ-H2AX, DNA content (Propidium 
Iodide: PI) and DNA synthesis (Ethynyl-deoxyUridine: EdU) showed that, following 
p21WAF1/Cip1 induction, DNA damage accumulated mainly in cells incorporating EdU, 
whereas depletion of Cdc6 and Cdt1 profoundly suppressed the accumulation of DNA 
damage in S-phase (Fig. 3e). Markedly, the cells expressing p21WAF1/Cip1 
demonstrated a focal PCNA pattern characterized by small dots that represents a trait 
of early S-phase (Essers et al. 2005)(Supplemental Fig. S10). This finding suggests 
that DNA damage occurs at a time sensitive slot, as current data demonstrate the 
presence of early replication fragile sites that are prone to breakage under conditions 
of replication stress (Barlow et al. 2013). 
 
4. p21WAF1/Cip1-mediated replication intermediate lesions are processed by 
MUS81-EME1 and repaired by a Rad52-dependent mechanism: To further 
characterize p21WAF1/Cip1-mediated replication stress we examined for single-stranded 
DNA (ssDNA) formation, a common intermediate at replication-associated lesions. 
To this end, p21WAF1/Cip1 expressing cells were incubated with BrdU for 24hs, under 
non-denaturating conditions, allowing anti-BrdU staining to disclose ssDNA (Beck et 
al. 2010). In line with our hypothesis, in situ analysis showed a strong co-localization 
between BrdU staining and p21WAF1/Cip1 expression (Fig. 4a), that was also associated 
with an increased number of foci formed by the ssDNA-binding protein RPA (Fig. 
4b). The ssDNA could be generated by replicative helicase – polymerase uncoupling 
(stalled fork), template-strand resection after double strand break (DSB) formation, 
unequal branch migration of stalled fork that yield reversed forks structures (chicken 
foot), or ssDNA gaps on template DNA (Petermann and Helleday 2010; Neelsen et 
al. 2013a; Couch et al. 2013)(Supplemental Fig. S11). To further discriminate 
whether ssDNA is from the template or the newly synthesized (nascent) strands short 
BrdU pulses (20 min) were used. The analysis did not show BrdU staining, suggesting 
that the source of the ssDNA is the template strand (Supplemental Fig. S12). 
Regardless of the way ssDNA is formed, it represents a structure of DNA replication 
intermediate lesions that need to be resolved for replication to restart. It has been 
reported that after long periods of replication inhibition double strand breaks (DSBs), 
generated by the structure-specific endonuclease complex of MUS81-EME1*, are 
required for restart (Hanada et al. 2007; Petermann and Helleday 2010). Based on 
this fact we hypothesized that sustained p21WAF1/Cip1 expression phenocopies the latter 
state involving MUS81-EME1. Indeed, MUS81-EME1 depletion caused a significant 
decrease of the DNA damage inflicted by p21WAF1/Cip1 expression, as well as reduction 
of the EdU positive cells harboring signs of DNA damage (Fig. 4c,d; Supplemental 
Fig. S13). Recent reports present MUS81-EME1 as a central player in oncogene-
induced genotoxicity (Neelsen et al. 2013b; Murfuni et al. 2013), promoting 
homologous recombination (HR)-mediated repair of inactivated (collapsed) forks 
(Petermann and Helleday 2010). Surprisingly, we noticed that silencing of the 
homologous repair recombinase Rad51 resulted in decreased γ-H2AX levels (Fig. 4e). 
This finding implies a negative control over an alternative, Rad51-indepenent, repair 
process. Rad51 was reported to exert such an effect preventing Rad52-dependent 
DNA annealing and repair (Wu et al. 2008). In fact, suppression of Rad52 was 
followed by increased γ-H2AX expression and cell death (Fig. 4f,g), suggesting that 
Rad52 guided the repair process. Rad52 is possibly involved in microhomolgy-
mediated repair pathways, which are considered mutagenic (Ottaviani et al. 2014) 
and according to latest data collapsed forks are recovered by error-prone replicative-
based mechanisms challenging genome stability (Iraqui et al. 2012). An interesting 
observation was that Rad51 levels were reduced upon p21WAF1/Cip1 induction. Rad51 is 
in short supply and under certain stressogenic conditions such as hypoxia it is 
repressed by E2F4/p130 complexes. Given that p53-dependent gene repression via 
p21WAF1/Cip1 is mediated by recruitment of such complexes (Benson et al. 2013), we 
hypothesized that protracted p21WAF1/Cip1 expression mimics such circumstances and 
examined whether the promoter of Rad51 is occupied by E2F4. Indeed it did (Fig. 
4h), providing a mechanistical explanation why Rad52 is the preferable repair choice 
in this setting. 
 5. Deregulated up-regulation of Cdt1 and Cdc6 links p53-independent activation 
of p21WAF1/Cip1 with senescence: The results so far showed that sustained p21WAF1/Cip1 
expression triggered senescence, a well established anti-tumor response (Bartkova et 
al. 2006; Halazonetis et al. 2008) that nonetheless, in a p53 null environment, 
harbored the seeds of genomic instability, in the form of deregulated licensing factors. 
P21WAF1/Cip1-imposed senescence was to a large extent mediated by Cdt1 and Cdc6, 
apparently as a result of the DNA damage checkpoints they activated (Fig. 5a,b) 
(Bartkova et al. 2006; Liontos et al. 2007). In a previous study we noticed that p73, 
the p53 homologue, responds to the DDR pathway (Liontos et al. 2009). As 
inappropriate expression of Cdt1 and Cdc6 caused replication stress and DNA 
damage we asked whether p73 could operate as the downstream effector of the 
emerging p21WAF1/Cip1–RLFs–DDR–signaling route, stimulating senescence. We 
found that p21WAF1/Cip1 induction elicited p73 up-regulation, in a Cdt1/Cdc6- 
dependent manner, that was essential for executing the senescent program (Fig. 5a,b). 
According to the oncogene-induced DNA damage concept for cancer development 
continuous formation of DNA breaks exerts a selective pressure on the DDR-induced 
anti-tumor barriers, eventually breaching them, leading to genomic instability and 
tumor progression (Halazonetis et al. 2008). If this holds true, then at some point the 
p21WAF1/Cip1 expressing cells will bypass the senescence barrier generating more 
aggressive offsprings. In addition, apart from fueling genomic instability (Sideridou 
et al. 2011), Cdc6 overexpression could confer to tumorigenesis by repressing the 
INK4/ARF locus (Gonzalez et al. 2006). Indeed, p21WAF1/Cip1 activation led to down-
regulation of both products of the INK4/ARF locus, p16INK4A and p14ARF, apparently 
as a result of Cdc6 up-regulation (Fig. 5c). Suppression of p16INK4A removes an 
indispensable factor for maintaining the senescent phenotype (Beauséjour et al. 
1999); thus rendering p21WAF1/Cip1-mediated senescence possibly reversible. 
 
6. Protracted expression of p21WAF1/Cip1, in a p53 loss of function 
environment, bypasses senescence, fuels genomic instability, promoting 
aggressive behavior: Monitoring the behavior of the cells we interestingly observed 
that after the 10th day of switching on p21WAF1/Cip1 the senescent phenotype gradually 
declined. Concurrently, a sub-population of non-senescent p21WAF1/Cip1 positive cells 
emerged (Fig. 6a) demonstrating, later than the 20th day of induction, BdrU and EdU 
incorporation values similar to those seen in the control counterparts (Fig. 6b,c; 
Supplemental Video 3). Likewise, around the same time period, the mutual exclusive 
relationship between cyclin A, an established late S/G2 marker (Woo and Poon 
2003; Pines and Hunter 1991), and p21WAF1/Cip1 was reduced, and accompanied by a 
double p21WAF1/Cip1/cyclin A positive sub-population (Fig. 6d). These results strongly 
suggest that a fraction of p21WAF1/Cip1 expressing cells evaded from p21WAF1/Cip1-
induced senescence and arrest, re-entering the cell cycle (from now on these cells are 
termed “escaped”). To support this observation, cdk2 activity as well as 
phosphorylation of the stimulatory site T160 of Cdk2 that were suppressed upon 
p21WAF1/Cip1 induction, were restored (Fig. 6e, Supplemental Fig. S14). Strikingly, 
the “escaped” cells showed a dramatic reduction of p73 expression that concurs with 
the decline of the senescent phenotype (Fig. 6e). Another interesting finding was that 
most of their nuclei were significantly larger than those of the un-induced cycling 
control cells (Fig. 6f, Supplemental Fig. S15, Supplemental Video 4), a feature that 
was also observed in vivo (Fig. 1). DNA damage formation was also reduced in the 
“escaped” cells implying that an extensive repair process took place (Fig. 6g). The 
involvement of the MUS81-EME1 - Rad52 repair route (Fig. 4c,d) and the increased 
presence of micronuclei (Fig. 7b) that are considered surrogate markers of 
chromosomal instability, defective DDR and repair (Terradas et al. 2009), point out, 
as mentioned already above, that the latter was error-prone. To gain a more precise, 
genome wide, view of this likely outcome we performed array comparative genomic 
hybridization (aCGH) analysis, deep sequencing and M/FISH/SKY combined with 
inverted-DAPI banding between the “escaped” and the un-induced cells (Fig. 7, 
Supplemental Fig. S16-S18; Supplemental Tables 4-5). In total six independent 
biological replicates were performed and the duration of each experiment was 30 days 
to produce an adequate amount of “escaped” cells for the analysis. To avoid cell 
culture propagation effects that could mask the effect of p21WAF1/Cip1 activation the 
OFF cells were cultured for the same period (Supplemental Fig. S16a). In aCGH the 
un-induced cells were used as reference; thus eliminating the noise showing only the 
differences between the two states (OFF vs ON). Cumulatively the results from all 
three experimental procedures clearly disclosed that the genome context of the 
“escaped” cells acquired chromosomal aberrations, in the form of gains and losses 
that ranged in size from approximately 1.75Kb to 92Mb (Fig. 7a, Supplemental Figs 
S16b,c, S17, S18; Supplemental Tables 4-5), as well as novel translocations (Fig. 
7c, Supplemental Fig. S16c). Interestingly among the genetic lesions found were 
alterations concentrated in the same chromosome bands (3p14.3, 3p14.2, 10p15.3) 
consisting of alternating regions of gains or losses with retention regions in between 
(Fig. 7a, Supplemental Table 4), most probably representing events of 
chromoanasynthesis or chromothripsis, respectively (Holland and Cleveland 2012). 
One of the most noteworthy observations of this multifaceted experimental approach 
was the strong concordance between the findings of the cytogenetic, aCGH and deep 
sequencing analyses (Fig. 7d, Supplemental Fig. S16-S18). Given that each 
experimental procedure took place at a different time period we can conclude that 
p21WAF1/Cip1 steers a “deterministic” set of genetic events that may play a role in the 
behavior of the “escaped” cells. In line with this notion the transcriptome of the 
“escaped” cells (Supplemental Fig S19,S20), using Monte-Carlo simulation, 
demonstrated a specific non-random correlation with the genomic alterations found in 
these cells (p<2.2*10-16). This finding suggests that a causality inference can be safely 
made since deregulation of the replication licensing machinery and particularly Cdt1 
was the first biochemical event to occur after p21WAF1/Cip1 stimulation; deducing that 
genomic instability led to the observed changes in the transcriptome of the “escaped” 
cells. Although p21WAF1/Cip1 is not a transcription factor it has been reported to 
enhance transcription, in certain cases by modulating the activity of transcription 
cofactors (Perkins et al. 1997). Nevertheless, the fact that only 42 (7.6%) of the 553 
genes found differentially expressed in the “escaped” cells were detected in earlier 
time-points (12, 48 and 96 hrs) provides further evidence that p21WAF1/Cip1-mediated 
transcription is most unlikely to be the driving force behind the emerged 
transcriptome of the “escaped” cells (Supplemental Fig. S21). 
The most important finding of the present study was that the 
descendent/“escaped” clones demonstrated significantly higher anchorage-
independent growth and were more invasive when evaluated in comparison with the 
un-induced cells (Fig. 6h,i). Even more they tolerated treatment with the genotoxic 
drugs, doxorubicin and cisplatin much more efficiently whereas, no significant 
difference in the response to taxol, a microtubule polymer stabilizer and mitotic 
inhibitor, was noticed (Fig. 6j). The enhanced resistance to doxorubicin and cisplastin 
remained even when p21WAF1/Cip1 activation was switched off in the “escaped” cells 
for 10 days, clearly denoting that this feature was independent from a potential 
p21WAF1/Cip1-mediated indirect transcriptional effect. As a final point, a number of the 
transcriptionally altered genes are reported to be functionally connected with 
aggressive behavior such as, invasion, metastasis and cancer “stemness” providing the 
ground to interpret the acquired aggressive phenotypic features (Supplemental Fig. 
S19)(Supplemental Table 6). 
 
 
 
Discussion  
The present report advances our understanding of how p21WAF1/Cip1 can exhibit 
oncogenic activities. The key factor in tipping the balance from the tumor suppressor 
function to that of an oncogene was p53 inactivation. Our data suggest a novel 
function for p53; that of protecting the cells from the adverse effects of p21WAF1/Cip1. 
Dissecting p21WAF1/Cip1 from the control of p53 demonstrated the ability of the 
former, when stimulated by p53-independent signals, to deregulate the replication 
licensing machinery. We provide evidence that continuous production of p21WAF1/Cip1 
saturates its degradation modules, CRL4CDT2 and SCFSkp2, leaving their other targets, 
including Cdt1 and E2F1/2 unabated to perform their function. Since Cdt1 and Cdc6 
represent E2F targets (Karakaidos et al. 2004; Schlisio et al. 2002) a putative 
consequence of this mechanism could be the formation of positive feedback loops 
boosting Cdt1 and Cdc6 expression (Fig. 7f). By up-regulating the pivotal replication 
licensing factors Cdt1, Cdc6 and Orc, the cells expressing p21WAF1/Cip1 acquire the 
capacity to re-replicate. Our work sheds new light on an earlier mechanistic 
observation, noticing that p21WAF1/Cip1 can promote “endo-reduplication” (Niculescu 
et al, 1998). It also goes one step further demonstrating experimentally that 
p21WAF1/Cip1-mediated re-replication guides a selective process giving rise to 
descendant cells with more aggressive features compared to their progenitors (Fig. 
7f). Re-replication is a form of replication stress in which the temporal separation of 
origin licensing and firing is lost. This feature leads to replication fork collapse, DNA 
damage and eventually genomic instability, if not repaired in an error-free manner 
(Blow and Gillespie 2008). In comparison to endo-reduplication (multiple 
consecutive S-phases with no passage through mitosis), which naturally takes place in 
certain types (Porter 2008), re-replication does not appear to occur as part of any 
physiological developmental program. Within this context, the p53 checkpoint was 
shown to hamper re-replication (Vaziri et al. 2003). It was also suggested that cells 
undergoing re-replication could be eliminated by apoptosis (Vaziri et al. 2003). This 
claim was clearly demonstrated in the p21WAF1/Cip1-IPTG-ON HT1080 cellular model 
(Fig. 2c), that harbors wt p53, further supporting our concept. The fact that the turn-
over of p21WAF1/Cip1 and Cdt1 is controlled by the same E3-ubiquitin ligases under-
scores the significance of p53 since its inactivation confiscates a protective 
mechanism. Having in mind that p21WAF1/Cip1 mutations are extremely rare events in 
cancer (Abbas and Dutta 2009), it is apparent that human cancers, with loss of p53 
function, are at risk of suffering additional deleterious genetic alterations by 
protracted operation of p21WAF1/Cip1, activated through p53-independent signaling 
routes. Among the p53-independent stimuli shown to induce p21WAF1/Cip1 are growth 
factors such as EGF, FGF2 and TGF-β frequently reported to be overexpressed in 
various types of human cancer (Abbas and Dutta 2009). 
The ensuing involvement of the HJ resolvase MUS81-EME-1 and the 
recombinase Rad52 points towards a replication-based error prone repair process. 
MUS81-EME-1 is a key player in oncogene-induced replication stress (Neelsen et al. 
2013b; Murfuni et al. 2013), whereas reduction of Rad51 generated the conditions 
for a switch from a high-fidelity homologous recombination to a lower fidelity 
process mediated by Rad52. Rad52-depedendent recombination requires much less 
homology (micro-homology) than Rad51 facilitating illegitimate events during repair 
(Ottaviani et al. 2014; Hastings et al. 2009; Wu et al. 2008)(Fig. 7f). This notion 
was confirmed by aGCH and molecular cytogenetics unraveling an altered genome 
landscape in the “escaped” cells. Characteristically among the lesions observed some 
strongly resembled the recently described complex chromosomal rearrangement of 
chromoanasynthesis that appears to result from replicative template-switching events 
(Fig. 7)(Zhang et al. 2013). Chromothripsis was another complex chromosomal 
rearrangement viewed (Fig. 7), considered to be the outcome of NHEJ (Stephens et 
al. 2011), implying that other repair pathways, possibly non-replicative ones, may be 
involved in p21WAF1/Cip1–driven genomic instability. In such a case, lesions that are 
not fixed during S-phase or the subsequent G2 by micro-homology-mediated 
procedures may be repaired in the next G1-phase by its preferred method, NHEJ 
(Ottaviani et al. 2014). In parallel to re-replication, p21WAF1/Cip1 can further promote 
genomic instability by suppressing, as reported, mismatch and nucleotide excision 
repair (Abbas et al. 2009). 
A question that always emerges when genomic alterations are acquired is whether 
they represented a passenger or a driver event. The fact that the transcriptomic 
changes showed a highly significant correlation (p<2.2*10-16) with the genomic ones 
strongly supports the latter notion. Among the transcripts found deranged were that of 
IGF1, FGFR2, MMP13 and CD44 well established for their role in cancer 
progression, possibly accounting for the aggressive behavior of the “escaped” cells 
(Supplemental Fig. S19,S20). Another up-regulated factor was ID2 shown to 
antagonize the suppressive effects of p16INK4A and p21WAF1/Cip1 (Sikder et al. 2003). 
That p21WAF1/Cip1-driven genome changes constitute part of a selection trajectory to 
promote survival and long term evolution was further illustrated by the finding that 
the descendent/“escaped” clones tolerated DNA damage much more efficiently when 
exposed to the genotoxic drugs, doxorubicin and cisplatin. Even when exogenous 
stimulation of p21WAF1/Cip1 was switched off the resistance to the DNA damaging 
agents remained impervious. This observation indisputably depicts that the “escaped” 
cells adapted to DNA damage inflicted by p21WAF1/Cip1-dependent re-replication and 
that this trait is independent from any potential p21WAF1/Cip1-mediated indirect 
transcriptional effect. 
Conclusively our results highlight a “dark side” of p21WAF1/Cip1 that should be 
taken into consideration when designing therapeutic strategies, particularly in p53-
null tumors, as a number of agents used in clinical oncology, such as dexamethazone, 
can activate p21WAF1/Cip1 in a p53-independent manner (Cha et al. 1998) with 
potential detrimental effects to patients. 
 
Material and Methods 
Tumor specimens 
Formalin-fixed, paraffin-embedded sections from 20 surgically removed head-neck 
carcinomas, 30 urothelial bladder carcinomas and 30 lung carcinomas were analyzed, 
after local ethical committee approval. Patients had not undergone chemo- or 
radiotherapy before surgical resection. The majority of clinical samples have been 
previously described (Liontos et al. 2007; Evangelou et al. 2013). 
 
Cell lines and culture treatments 
Saos2 Tet-ON p21WAF1/Cip1 (human osteosarcoma), H1299 p21WAF1/Cip1–Ponesterone-
ON (human lung carcinoma) and HT1080 p21WAF1/Cip1-9 (human fibrosarcoma) 
carrying Tet-ON, ponesterone and isopropyl-b-D-thiogalactoside (IPTG)-inducible 
p21WAF1/Cip1 respectively (Bates et al. 1998; Chang et al. 1999; Wang et al. 1999), 
MCF7 (human breast cancer) and MDA-MB-231 (human breast cancer) cell lines 
were maintained in DMEM (Invitrogen) with 10% FCS (Invitrogen), 2mM l-
glutamine (Invitrogen), and 100 μg/ml penicillin and streptomycin (Invitrogen) at 
37°C and 5% CO2. Growth and maintenance of Li-Fraumeni Syndrome (LFS) 
fibroblasts was as previously described (Bischoff et al. 1990). 
For p21WAF1/Cip1 expression induction, Saos2 p21WAF1/Cip1 cells were treated with 
2μg/ml Doxycycline (Applichem), while HT1080 p21WAF1/Cip1-9 cells were treated 
with 100μM IPTG (Ambion). MCF7 and MDA-MB-231 cells were treated with 5 
ng/ml TGF-β. 
Microphotographs were obtained on an inverted microscope (Axiovert S100; Carl 
Zeiss) with CP-Achromat objectives and a charge-coupled device IRIS high-
resolution color video camera (SSC-C370P; Sony), whereas the Image Pro Plus v3.0 
(Media Cybernetics) was used for image acquisition. 
 
siRNA transfections and retrovirus infections 
Cdc6, Cdt1, Rad52 (Invitrogen), Rad51 (Thermo Scientific) and Mus81 (Santa Cruz) 
siRNA gene silencing was performed as previously described (Liontos et al. 2009). 
Briefly, 3×105 cells plated in 60mm dishes were transfected using Lipofectamine 
2000 (Invitrogen) with the appropriate RNAi pool (set of three siRNAs from the 
manufacturer) or the corresponding RNAi negative control (Invitrogen) as per 
manufacturer’s guidelines. Cells were harvested 48h after transfection for further 
analysis. 
LFS cells were transiently infected with the pBabe-p21WAF1/Cip1 or the corresponding 
control vector using the Phoenix helper-free retrovirus producer cell line as described 
before (Sideridou et al. 2011). H1299 cells were transiently infected with the 
pMSCV, pMSCV-p21WAF1/Cip1 or pMSCV-p21PCNA (a mutant p21WAF1/Cip1 harboring 
Q144, M147, F150 substitutions to A in its PIP degron motif) vectors using the 
Phoenix helper-free retrovirus producer cell line (Abbas et al. 2008). 
 
Immunohistochemistry (IHC) 
The following antibodies were used: p21WAF1/Cip1 (1:200, Santa Cruz) and Ki67 
(1:100, Dako). IHC was performed using the UltraVision LP Detection System 
(Thermo Scientific) as per manufacturer’s instructions. Paraffin sections (4 μm) were 
deparaffinised in xylene and rehydrated in a graded series of ethanol-aqueous 
solutions. Antigen retrieval was carried out in 10mM citrate buffer (pH 6.0) by 
heating the slides for 25min in a microwave oven. Endogenous peroxidase activity 
was blocked with 3% hydrogen peroxide in TBS for 10min. Primary antibodies were 
incubated overnight. Evaluation and controls were as previously described 
(Evangelou et al. 2013). 
 
Indirect Immunofluorescence (IF) 
Indirect IF analysis was performed as previously published (Liontos et al. 2007). 
Briefly, cells grown on coverslips were fixed in 4% formaldehyde and permeabilized 
by 0.1% Triton X-100 in two 15 min consecutive steps, at RT. After washing with 
PBS, cells were blocked for 30min in 10% FCS. FFPE tissues sections were used after 
dewaxing and rehydration as described in the IHC paragraph. Primary antibodies used 
were: p21WAF1/Cip1 (1:200, Santa Cruz), Ki-67 (1:300, Dako), histone H2A.X 
phosphorylated at serine 139 (1:300, Millipore), Cyclin A (1:200, Santa Cruz), 53BP1 
(1:200, Abcam), PCNA (1:100, Santa Cruz), Rad51 (1:200, Santa Cruz,) and hRPA32 
(1:1000, Genetex). Cells were then incubated with primary antibodies at 4°C 
overnight. Secondary antibodies Alexa Fluor® 488 goat anti-rabbit (1:500, 
Invitrogen) and Alexa Fluor® 568 goat anti-mouse (1:500, Invitrogen) were applied 
for 60min at RT, followed by final wash in PBS. Counterstaining was performed with 
100 ng/ml of 4,6-diamidino-2-phenylindole (DAPI)(Sigma-Aldrich). Image 
acquisition of multiple random fields was automated on a ScanR screening station 
(Olympus) and analyzed by using ScanR (Olympus) analysis software, or a Zeiss 
Axiolab fluorescence microscope equipped with a Zeiss Axiocam MRm camera and 
Achroplan objectives while image acquisition was performed with AxioVision 
software 4.7.1. 
 Total protein extraction and immunoblotting 
Total protein extracts. Total protein extraction was performed as described before 
(Liontos et al. 2007). Briefly, cells were homogenized in 50 mmol/L HEPES pH 7.5, 
150 mmol/L NaCl, 15 mmol/L ß-mercaptoethanol, 0.5 mmol/L 
phenylmethanesulfonyl fluoride (PMSF), 0.1% Nonidet P-40 (Sigma) and centrifuged 
at 1000xg at 4°C for 10min. The supernatant was collected and adjusted to 1µg/ml 
protease and phosphatase inhibitors (Pierce). The pellet was resuspended in 10mM 
HEPES pH 7.9, 1.5mM MgCl2, 10mM KCl, 0.5mM DTT, and 1.5mM PMSF, 
incubated on ice for 30min and centrifuged at 1000xg at 4°C for 10min. The 
supernatant fraction containing histones was collected. Total protein and histone 
concentration was evaluated using the Bio-Rad Protein Assay (Bio-Rad). 
Biochemical cell fractionation. Cells (2-5x106) were collected and re-suspended in 
200μl buffer A (10mM Hepes pH7.9, 10mM KCl, 1.5mM MgCl2, 0.34M Sucrose, 
10% glycerol, 1mM DTT, protease and phosphatase inhibitors)(Supplemental Fig. 
S8a). Following, 0,1% Triton X-100 was added and then incubated for 6min on ice. 
Next lysates were centrifuged at 1300g/4oC for 5min. The supernatant (S1) fraction 
was clarified by centrifugation for 15min at 20000g/4oC to remove cell debris and 
insoluble aggregates. The resultant supernatant, soluble fraction was used as cytosolic 
(S2) one. The pellet from the initial lysate was first washed with buffer A and then 
subjected to further lysis in buffer B (3mM EDTA, 0.2mM EGTA, 1mM DTT, 
protease and phosphatase inhibitors) for 30min on ice. Subsequently, a centrifugation 
of 5min at 1700g/4oC was applied. The supernatant was collected as the soluble 
nuclear (S3) fraction. The pellet was washed in buffer A and then centrifuged for 5 
min at 1700g/4oC. Finally, the pellet was re-suspended in buffer A to obtain the 
chromatin fraction (P3)(Supplemental Fig. S8a). 
Primary antibodies employed were: p21WAF1/Cip1 (1:400, Santa Cruz), Cdc6 (1:1000, 
Millipore), Cdt1 (1:400, Santa Cruz), H2AX (1:1000, Abcam), γH2AX (1:1000, 
Millipore), p73 (1:1000, NeoMarkers), Mus81 (1:400, Santa Cruz), Cdk2 (1:1000, 
Santa Cruz), Cdk2-pT160 (1:1000, Cell Signalling), Cdk2-pY15 (1:1000, Santa 
Cruz), PLK1 (1:1000, Santa Cruz), TOP2A (1:1000, Santa Cruz), β-actin (1:1000, 
Cell Signalling), p14ARF (1:100, Abcam), Cyclin A (1:1000, Santa Cruz), histone H3-
pS10 (1:1000, Abcam), Cdk1 (1:400, Santa Cruz), Rad51 (1:500, Santa Cruz), Rad52 
(1:500, Santa Cruz), MCM7 (1:1000, Abcam) and p53 (1:1000, Santa Cruz). 
Thirty µg of protein from total extracts or 1μg of histones from each sample were 
adjusted with Laemmli Buffer (Sigma) and loaded on PAGE gels. Gel electrophoresis 
and transfer to PVDF membrane (Millipore) were performed according to standard 
protocols. Blots were blocked for 1h in 5% non-fat milk in TBS-0.1% (v/v) Tween-20 
solution at RT. Subsequently, membranes were incubated overnight with primary 
antibody solution in 0.5% non-fat milk in TBS with 0.1% (v/v) Tween-20 at RT, 
followed by a 45min incubation with alkaline phosphatase conjugated anti-mouse or 
anti-rabbit secondary antibody (1:5000 dilution)(Promega) at RT. Signal development 
was performed with nitro blue tetrazolium/5-bromo-4-chloro-3-indolylphosphate 
(NBT/BCIP) solution (Molecular Probes) as previously described (Sideridou et al. 
2011). 
 
CDK2 kinase activity 
For each sample, 50mg of total-cell protein extract was precleared for 2h at 4°C with 
5mg of rabbit immunoglobulin G (anti-Cdk2) or 5 mg of mouse immunoglobulin G 
(anti-cyclin B1) prebound to protein A-Sepharose (Millipore). Precleared lysates were 
transferred to new microcentrifuge tubes and incubated with anti-Cdk2, or anti-cyclin 
B1 with mixing for 2h at 4°C. Protein A-Sepharose was added and the samples were 
mixed for 2h at 4°C. The immunoprecipitates were washed twice with TBS and twice 
with kinase buffer (100mM Tris pH 7.4, 20mM MgCl2, 2mM dithiothreitol) before 
incubation with 5mg of histone H1 (Boehringer Mannheim) and 15nM ATP for 
10min at RT. Samples were incubated with Malachite Green Reagent for 30min 
(Cdk2 and Cyclin B1). The kinase assay mixtures were quantified with optical density 
at 620nm by subtracting negative control. 
 
Flow cytometric analysis (FACS) 
For cell cycle analysis, cells were collected by trypsinization and fixed in 70% ethanol 
at 4oC for 15min. After fixation, cells were washed with PBS, and the DNA was 
stained with propidium iodide (50μg/ml), in the presence of 5mM MgCl2 and 10μg/ml 
RNAse A in 10mM Tris HCl pH 7.5. DNA content was assessed on a FACS Calibur 
(Becton-Dickinson). 
For BrdU pulse-chase proliferation assays, cells were pulse labeled with 10μM BrdU 
(Roche) for 1h, fixed in 70% ethanol, and incubated in 2M HCl for 30min. Cells were 
incubated with mouse antibody against BrdU (1:100) for 1h. For EdU analysis, cells 
were either pulsed for 10min with 10μM EdU or 24h. Cells were fixed in 70% ethanol 
and incubated with mouse anti–g-H2AX (1:100, Millipore) or mouse anti-p21WAF1 
(1:100, SantaCruz) for 30min, followed by further 15min incubation with Alexa Fluor 
488 anti–mouse IgG (1:100, Invitrogen) or anti-mouse E-Phycoerythrin (1:100, 
Invitrogen). EdU was detected with a Click-iT EdU Cell Proliferation Assay kit 
(Invitrogen). For MCM2 staining, cells were washed in wash buffer (1% (w/v) BSA 
in PBS) and unbound MCM2-7 was extracted in CSK buffer (10 mM HEPES, 
100mM NaCl, 3mM MgCl2, 1mM EGTA, 300mM sucrose, 1% BSA, 0.2% Triton-
X100, 1mM DTT, 1mM PMSF, 10ng/ml Pepstatin, 10 ng/ml Leupeptin and 10 ng/ml 
Aprotinin) on ice for 10 min. Extracted cells were fixed in 2% (v/v) paraformaldehyde 
in PBS for 10 min at 37°C, washed twice and stored in wash buffer at 4°C until 
staining. CSK extracted fixed cells were permeabilised in 70% ethanol, washed and 
incubated for 1h at RT with mouse anti-human MCM2 (1:500, BD Biosciences). Next 
cells were washed and incubated for 30 min at RT in dark with Alexa Fluor 488 goat 
anti-mouse IgG (1:500, Life Technologies), before being washed twice and re-
suspended in 50 µg/ml 7-AAD (7-aminoactinomycin D, Life Technologies) diluted in 
wash buffer. Samples were analysed using FACS Canto (Becton Dickinson) and BD 
FACS DIVA software (BD Biosciences). Data analysis was performed using Flowjo 
(v7.6.5, Tree Star Inc.). 
 
Comet Assay 
Comet assay was performed as previously described (Sideridou et al. 2011). Briefly, 
105 Saos2 p21WAF1/Cip1 cells induced or non-induced with doxycyclin were seeded in 
60mm dishes, respectively. Two days later cells were trypsinized, centrifuged, 
resuspended in 2ml PBS and kept on ice for 10min. Viable cells were counted using 
Trypan blue and PBS was added to adjust the number of cells to 105 in 500μl of PBS. 
50μl of PBS containing cells were then mixed with equal volume of low-melting 
agarose 1,7% (w/v) and were embedded in plugs. Plugs were incubated in 50ml of 
lysis solution (100mM TrisHCl pH 10.0, 100mM EDTA, 2.5M NaCl, 1% (v/v) Triton 
X100, 10% (v/v) DMSO) for 1h on ice and in dark. After lysis, plugs were washed 
twice in 1xTBE for 1h on ice in dark. Finally, plugs were washed and incubated in 
ice-cold alkaline denaturation buffer (300mM NaOH, 1mM EDTA, pH 13) for 45 min 
on ice in the dark. Plugs were mounted onto 1% agarose coated slides that were 
placed into a 30-cm horizontal constant-field gel electrophoresis chamber in ice-cold 
alkaline denaturation buffer for 20min at 0.7 V/cm and at 4oC. After electrophoresis, 
slides were dehydrated in ice-cold ethanol (100%) for 10min and allowed to dry in the 
dark. After 24h slides were rehydrated in 5ml of deionized water for 10min and 40μl 
of 1x SYBR Green (Invitrogen) were applied on each plug. Cells were observed under 
a fluorescence microscope equipped with a monochrome CCD camera. Analysis was 
conducted using the Cometscore software (Tritek). 
 
Pulse-field gel electrophoresis (PFGE) 
PFGE was performed as previously described (Beck et al, 2010). Briefly cells were 
embedded in a 0.8% agarose plugs (2.5x105 cells/plug), digested in lysis buffer 
[100mM EDTA, 1%(w/v) sodioum lauryl sarcosyne, 0.2% (w/v) sodium 
deoxycholate and 1mg/ml proteinase K] at 370C for 48h and washed in 10mM Tris-
HCl pH8.0 and 100mM EDTA. Electrophoresis was performed at 150C in 0.8% (w/v) 
PFGE certified agarose (Bio-Rad Laboratories) with Tris-borate/EDTA buffer 
employing a CHEF DR III apparatus (9h, 1200), 5.5V/cm, 30-18s switch time)(Bio-
Rad). The gel was stained with ethidium bromide. 
 
DNA fiber spreadings 
DNA fiber assay was performed as previously described with slight modifications 
(Bartkova et al. 2006). Briefly, Saos2 p21WAF1/Cip1 cells were grown in the presence 
or absence of doxycyclin for 4 days and then pulsed-labeled with 25M CldU for 
20min, and then labelled with 250M IdU for 20min. The cells were then harvested 
and lysed on glass slides in spreading buffer. The DNA was denatured and stained 
with rat anti-BrdU/CldU (1:1000, Immunologicals Direct) and mouse anti-IdU/BrdU 
(1:500, Becton Dickinson) primary antibodies.  
 
Senescence staining 
Saos2 p21WAF1 cells were Doxycyclin induced at the time points indicated (Fig. 5), as 
described above. Subsequently, cells grown on coverslips were transfected with 
control siRNA, or anti-Cdc6 and/or anti-Cdt1 siRNAs. Control (OFF) and induced 
cells were fixed in 1% paraformaldehyde and then processed for Sa-β-gal or Sudan 
Black B staining and counterstained with nuclear fast red, as described elsewhere 
(Georgakopoulou et al, 2013). Only cytoplasmic staining was scored as positive 
signal. 
 
MTT Assay 
Cytotoxicity was estimated by the MTT assay (Eliades et al. 2009). Briefly, cells 
were plated in 96-well, flat-bottomed microplates at a density of approximately 
15,000 cells/cm2, in DMEM containing 10% FBS. 24h after plating, the medium was 
replaced containing the chemotherapeutic agents at the concentrations indicated. After 
72h of incubation, the medium was replaced with MTT dissolved at a final 
concentration of 1 mg/ml in serum-free, phenol-red-free DMEM, for further 4h 
incubation. Then, the MTT formazan was solubilized in isopropanol, and the optical 
density was measured at a wavelength of 550nm and a reference wavelength of 
690nm. 
 
Isolation of nucleic acids  
DNA extraction: cells were lysed in 50mM Tris-HCl (pH 8.0), 150mM NaCl, 5mM 
EDTA, 1% SDS in the presence of proteinase K (0.1mg/ml) until completely 
dissolved. DNA was extracted with phenol/chloroform and RNase (Sigma) digestion, 
followed by ethanol precipitation (Liontos et al. 2007).  
RNA was extracted with the RNeasy Mini Kit (Qiagen). cDNA was generated with 
Superscript® II Reverse Transcriptase (Invitrogen) and oligo-dT (Invitrogen). 
 
cDNA preparation and real time RT-PCR 
Real-time reverse transcription PCR (RT-PCR) analysis employed the Platinum 
SYBR Green qPCR SuperMix-UDG (Invitrogen) and was run on an ABI Prism 7300 
cycler (Applied Biosystems)(Evangelou et al. 2013). Primer sequences and annealing 
temperatures are provided in Supplemental Table 7. Results are presented as n-fold 
changes for the various time points after p21WAF1/Cip1 induction versus the values of 
the non-induced sample. Mean value was calculated from three independent 
measurements. 
 
Soft agar assay 
Dishes of 60mm were layered with 3ml 0.7% (w/v) SeaPlaque Low Melting Point 
Agarose (Lonza) dissolved in serum-containing medium (Sideridou et al. 2011). 
Saos2 Tet-ON p21WAF1/Cip1 cells (25×103) were then mixed with 1.6 ml of 0.35% 
(w/v) warm agar (42oC) in serum-containing medium and plated on the solidified 
agarose layer. Agar was added weekly and foci were enumerated on day 45. 
Experiments were performed in three independent replicates. 
 
Invasion assay 
Saos2 Tet-ON p21WAF1/Cip1 cells were seeded on top of matrigel-coated transwell 
(Beckton Dickinson) at 5,000 cells per 24-well with serum-free medium (Sideridou 
et al. 2011). Transwells were embedded into complete (full-serum) culture medium 
and cells were allowed to invade for 24h. Finally, cells at the top side of the well were 
scraped, and cells (invading) on the bottom side of the well were stained with Giemsa, 
photographed and counted. Three independent measurements were averaged and the 
corresponding s.e. is also reported. 
 
Chromatin immunoprecipitation (ChIP) assay 
ChIP assay was performed as previously described (Sideridou et al. 2011). A 100 bp 
fragment in the Rad51 promoter and a 110bp amplicon, located approx 1000bp from 
the transcription start site (Fig. 4h), were amplified. Primers and annealing 
temperatures are provided in Supplemental Table 7. As inputs we used products that 
corresponded to PCR reactions containing 1% of the total chromatin extract used in 
the immunoprecipitation reactions. 
 
Proteomics 
Protein Digestion and iTRAQ Labeling. Cell pellets were dissolved in 200uL 
dissolution buffer [0.5M triethylammonium bicarbonate (TEAB), 0.05% SDS] with 
vortex mixing, 5min heating at 90°C and pulsed probe sonication for 20sec. Non 
dissolved cellular debris was separated from the protein solution with centrifugation 
at 13,000 rpm for 10min. For each sample a total protein amount of 100 μg was 
measured with Bradford assay (Bio-Rad Protein Assay) and diluted with the addition 
of dissolution buffer up to a final 20μL volume. The reduction, cysteine blocking and 
iTRAQ labeling were conducted in accordance to manufacturer protocols (AB Sciex) 
as reported before (Delehouze et al. 2013; Papachristou et al. 2013). The pooled 
whole sample mixture was split in two equal parts, lyophilized and stored at -20°C. 
High-pH Reverse Phase (RP) Peptide Fractionation. To one-half of the iTRAQ 
labeled sample described above, peptide fractionation was performed with reverse 
phase C18-liquid chromatography (XBridge, 150x4.6 mm, 3.5 μm; Waters) under 
alkaline conditions using the Dionex P680 pump equipped with a PDA-100 
photodiode array detector as described before (Papachristou et al. 2013). Fractions 
were collected in 1min intervals and lyophilized to dryness and stored at -20°C until 
LC-MS analysis. 
Hydrophilic Interaction Chromatography (HILIC) peptide fractionation. The second 
half of the iTRAQ labeled peptides was fractionated with Hydrophilic Interaction 
Chromatography (Core-Shell Kinetex, 150×2.1 mm, 2.6 μ, 100 Ȧ column) 
(Phenomenex) under acidic conditions using the Dionex P680 pump equipped with a 
PDA-100 photodiode array detector using gradient conditions as described by the 
authors (Garbis. et al. 2011; Delehouze et al. 2013). Fractions were collected in a 
peak dependent manner based on the absorbance signal response at 280nm, 
lyophilized to dryness and stored at -20°C until LC-MS analysis.  
LC-MS Analysis. All LC-MS experiments were performed with nano-Ultra-high 
performance liquid chromatography (Ultimate 3000, Thermo Fisher Scientific) 
hyphenated with a nanospray ionization / ultra high-resolution LTQ FT-Orbitrap-Elite 
mass spectrometer (Thermo Fisher Scientific) system. Individual high-pH RP and 
HILIC peptide fractions were reconstituted in 30μL loading solution (aqueous 0.1% 
formic acid, 2% acetonitrile). Sample volumes of 2μL volume were injected and 
loaded for 8min on the Acclaim PepMap 100, 100 μm × 2 cm C18, 5 μm, 100 Ȧ 
trapping column with the loading pump at a flow rate of 5 μL/min. The trapped 
peptides were then gradient separated with reverse phase C18-nano-capillary liquid 
chromatography (Acclaim PepMap RSLC, 75 μm×25 cm, 2μm, 100 Ȧ) (Thermo 
Fisher Scientific) under acidic conditions, and nano-spray ionized with the PicoTip 
emitter (FS360-20-10-D-20-C7, New Objective), as previously described 
(Papachristou et al. 2013). Gaseous phase transition of the separated peptides was 
achieved with positive ion electrospray ionization applying a voltage of 2.5 kV. For 
every MS survey scan, the top 10 most abundant multiply charged precursor ions 
between m/z ratio 350 and 1900 and intensity threshold 500 counts were selected with 
FT mass resolution of 240,000 and subjected to HCD fragmentation with an isolation 
window of 1.2 Da. Tandem mass spectra were acquired with FT resolution of 15,000 
within m/z range of 100-1900. Normalized collision energy was set to 35 and already 
targeted precursors were dynamically excluded for further isolation and activation for 
30sec with 5ppm mass tolerance. 
Database search. The HCD tandem mass spectra collected from RP and HILIC 
fractions were submitted to Sequest search engine implemented on the Proteome 
Discoverer software v1.3.0.339 for peptide and protein identifications. All spectra 
were searched against a UniProt Fasta file containing 20,200 human reviewed entries. 
The Sequest node included the following parameters: Precursor Mass Tolerance 10 
ppm, Fragment Mass Tolerance 20 mmu, Dynamic Modifications were Oxidation of 
M (+15.995 Da), Deamidation of N, Q (+0.984 Da), Phosphorylation of S (+79.966 
Da) and Static Modifications were iTRAQ8plex at any N-Terminus, K, Y (+304.205 
Da) and Methylthio at C (+45.988 Da). The Percolator node was used for the 
determination of the confidence level for peptide identifications with decoy database 
searching. Strict FDR was set to 0.01, relaxed FDR was set to 0.05 and validation was 
based on q-Value. The Reporter Ion Quantifier node included a custom iTRAQ 8plex 
(Thermo Scientific Instruments) Quantification Method, integration window tolerance 
20 ppm and integration method Most Confident Centroid. Protein ratios were 
normalized to protein median and peptides with missing iTRAQ channels were 
excluded from relative protein quantification. Phosphorylation localization probability 
was estimated with the phosphoRS node. 
 
High-throughput whole genome analyses 
aCGH analysis. Genomic DNA from 30days induced and non-induced Saos2 
p21WAF1/Cip1 cells was extracted using the BioRobot® M48 System (Qiagen) and the 
MagAttract® DNA Blood Midi M48 Kit (Qiagen). Quality and quantity of the DNA 
samples was determined on a NanoDrop ND-1000 spectrophotometer.  
Agilent Human Genome CGH 4x180K and 1x1MK microarrays were used (Agilent 
Technologies). The 4x180K platform is composed of more than 170,000 60-mer 
oligonucleotide probes with average spatial resolution of 13-25 Kb (NCBI build 37, 
hg19). The 1x1MK platform is composed of more than 963,000 60-mer 
oligonucleotide probes for the mapped genes or unique DNA sequences with an 
average spatial resolution of 2.1 Kb (NCBI build 37, hg19). Labelling and 
hybridization was carried out according to manufacturer’s guidelines. Data were 
processed using Feature Extraction 10.7.3.1 and analysed using Cytogenomics 
2.7.22.0 software (Agilent) with the following settings: Algorithm: ADM-1, 
Threshold: 6.7, with a minimum of 4 probes for a region to be included. 
Centralization and fuzzy zero corrections were applied to remove putative variant 
intervals with small average log2 ratios.  
Deep (next generation) sequencing (NGS). Genomic DNA from 30 days induced and 
non-induced Saos2 p21WAF1/Cip1 cells was used for whole genome sequencing. The 
library preparation and the whole genome sequencing were carried out in EMBL 
Genecore facility according to the Illumina platform. 
Whole genome sequencing was performed in “OFF” and “ON” cells achieving a 30x 
coverage of the human genome.  Paired-end 2x100 bp was performed with the use of 
Illumina Hi-seq 2000. Quality control of the reads was performed with the use of 
fastqc software (Ramirez et al. 2013) and alignment to the human genome 
(GRCh37/hg19 version) was performed with bowtie 2 algorithm (Langmead and 
Salzberg 2012) with the use of the following code (-D 5 -R 1 -N 1 -L 22 -i S0,2,.50 –
trim3 25 -I 0 -X 500). Samtools (Li et al. 2009) was used to convert sam files to bam 
and for sorting bam files. Breakdancer software (Chen et al. 2009) was utilized in 
order to identify SV (intra- & inter- chromosomal translocations, deletions, insertions 
and inversions). Taking into consideration the spacing between the two paired ends in 
the sequencing process we filtered out SVs with less than 500 bp length (deletion, 
insertion, inversion). 
Use of breakdancer with default parameters led to the identification of 103 new inter-
chromosomal translocations in “ON” cells versus “OFF” cells. 
In order to identify microhomology regions in the 103 inter-chromosomal 
translocations we used the coordinates from the breakdancer output and extented 30bp 
on both sides of the breakpoint-junction. Clustal W was used for aligning the regions 
around the 103 breakpoint junctions. Microhomology regions identified on the 
breakpoint spanned from 1-9 bp. 
Expression microarray analysis. Total RNA was isolated from non-induced and 12h, 
48h and 96h induced Saos2-p21WAF1/Cip1 Tet ON cells, using RNeasy Total RNA kit 
(Qiagen). Microarray analysis was performed by the microarray unit of CBM Core 
Facility Italy (http://www.cbm.fvg.it) using Illumina’s Whole-Genome Expression 
Beadchip. This platform targets more than 47,000 probes derived from the National 
Center for Biotechnology Information Reference Sequence (NCBI) RefSeq Release 
38 and other sources. Integrity of total RNA was evaluated using capillary 
electrophoresis (Bioanalyzer 2100, Agilent) and quantified using a Nanodrop 1000. 
Aliquots of RNA (250 ng) samples were amplified according to the specifications of 
the Illumina® TotalPrep™ RNA Amplification Kit (Ambion) to produce a pool of 
biotin-labeled RNA corresponding to the polyadenylated (mRNA) fraction. The 
cRNA samples were applied to whole-genome HumanHT-12 v4.0 arrays (Illumina) 
and hybridized according to manufacturer’s specification. Each array on the 
BeadChip targets over 29.000 transcripts using 3-micron beads bearing covalently 
attached 50-base oligonucleotide probes. Each probe interrogates a single gene, and 
each bead type is represented with an average 30-fold redundancy on every array. The 
BeadChips were scanned with the Illumina's Beadarray system scanner (Illumina). 
The hybridization images signal intensity was extracted and background subtracted 
using Illumina Inc. BeadStudio software v3.3.7. Data were checked for the Illumina 
internal quality control. 
To compare the non-induced and “escaped” Saos2-p21WAF1/Cip1 Tet-ON cells gene 
expression profile, total RNA was extracted using Trizol (Life Technologies) and 
choloroform/isoamyl alcohol (49:1). All RNA samples had a 28S/18S rRNA ratio 
close to 2 on 1.5% agarose gels, and absorbance ratios 260/280 nm between 1.9 and 
2.1. Targets were prepared using the GeneChip Whole Transcriptome (WT) Plus 
reagent kit and hybridized to Affymetrix GeneChip Human Transcriptome array 2.0 
(HTA 2.0) that contains over 6 million probes representative of 245,000 coding 
transcripts and 40,000 non-coding transcripts, as well as 339,000 probe sets covering 
exon-exon junctions. 
 
Molecular Cytogenetics  
Saos2 Tet-ON p21WAF1/Cip1 cell cultures were exposed to colcemid (0.1μg/ml) (Gibco) 
for 12h, at 37°C in 5% CO2. Cells were harvested by trypsinization (Gibco), 
suspended in medium, and spun down (10min, 1000 rpm). Supernatant was removed 
and 5ml of 0.075M KCl at RT was added drop by drop. Cells were incubated for 
20min at RT, and then 1ml of fixative [3×methanol (Applichem)/1×CH3COOH 
(Merck)] was added. Cells were spun down (10min at 1000 rpm), supernatant was 
removed, fixative was added and the cells were re-centrifuged for 10min at 1000 rpm. 
Finally, cells were dropped onto wet microscope slides and left to air-dry. For 
analysis, we combined inverted 4′,6′-diamidino-2-phenylindole (DAPI) Banding, and 
molecular karyotyping by M-FISH (MetaSystems). Multicolor FISH was performed 
according to manufacturer’s protocols (MetaSystems). For inverted DAPI banding, 
slides were counterstained and mounted with 0.1μg/ml DAPI in Vectashield antifade 
medium (Vector Laboratories). Analyses were performed using a 63× magnification 
lens on a fluorescent Axio-Imager Z1, Zeiss microscope, equipped with a 
MetaSystems charge-coupled device (CCD) camera and the MetaSystems Isis 
software. 
 Bioinformatic analysis 
Transcriptome and Proteome analyses from non-induced, 12h, 48h and 96h induced 
Saos2-p21WAF1/Cip1 Tet-ON cells. Protein and gene ratios (time-point/time-0) were 
log(2) transformed and centered. The 95% confidence intervals of the averaged log2-
ratios were calculated for each time-point to determine the statistically significant 
thresholds of over-expression and suppression. Time-series log2-ratio sets for each 
protein and gene where analyzed by ANOVA to detect a statistically significant 
change anywhere within the three time-points taking into account that each time point 
had 2 replicates for proteomics and 3 replicates for micro-arrays. Proteins and genes 
whose log-2-ratio was above or below the aforementioned over-expression and 
suppression thresholds respectively and their ANOVA p-value was <0.05 were 
considered regulated. All calculations were performed with R. The “Gene-Set 
Enrichment Analysis” algorithm with False-Discovery-Rate (FDR) correction was 
applied on the Gene-Ontology Biological-Process sets through the Ariadne Genomics 
Pathway Studio v9.0 to detect which functional groups where non-randomly impacted 
(FDR adjusted p-values <0.05 where considered significant). Pathway visualization 
for all data-sets was performed with Ariadne Genomics Pathway Studio v9.0. 
Transcriptome analysis from non-induced and “escaped” Saos2-p21WAF1/Cip1 Tet-ON 
cells. The Affymetrix .CEL files generated were analyzed using Partek Genomics 
Suite. Following normalization with the Robust Multi-array Average (RMA) 
algorithm, a full set of quality control analysis (which led to the exclusion of one 
sample) was performed followed by Power Analysis, Principal Component Analysis, 
and one-way ANOVA analyses for a range of different fold (2-5) and false discovery 
rate (0.001-0.05) thresholds. For the Hierarchical Clustering of significantly changed 
transcripts the level of each transcript was standardized to mean 0 and standard 
deviation of 1. 
The significantly changed transcripts identified for thresholds of > 2fold and < 
0.01FDR were analyzed using the Ingenuity Pathway Analysis software. Specifically, 
all direct and indirect relationships were considered, all data sources, and only 
experimentally observed information. Five levels of analysis were performed: 
Functional Categorization, Canonical Pathway analysis, Network analysis, Regulator 
Effects analysis, and Upstream Regulator analysis. 
Deep (next generation) sequencing (NGS) and aCGH data comparison. To compare 
the NGS data with the aCGH one regarding DNA copy number aberrations in 
“escaped” (ON) cells versus control (OFF) cells, the NGS data were processed as 
follows: a) Genomic regions presenting less than 10-times coverage were filtered out 
to ensure data high-quality, b) The log2 of the ratio of the normalized reads in the 
“escaped” cells  over the normalized number of reads in the control-cells was 
calculated, c) For each chromosome the aforementioned log2-ratios underwent DNA 
copy-number segmentation analysis utilizing the circular binary segmentation 
algorithm through the Bioconductor package “DNAcopy” (Venkatraman and 
Olshen 2007). All statistical analysis was carried out with R. 
Pathway Analysis. Proteins and genes from proteomics and transcriptomics 
respectively were imported into Ariadne Pathway Studio v9.0 and analyzed for 
biological context against Ariadne's canonical cell-process pathways utilizing the in-
built Gene Set Enrichment Analysis procedure which uses the Mann-Whitney U-Test 
to evaluate the pathways enrichment p-values that where adjusted according to the 
FDR correction for multiple testing. The confidence-level was 95%; thus p-values 
<0.05 where considered significant. 
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Figure legends 
Figure 1. The p21WAF1/Cip1 and Ki67 are co-expressed in a subset of atypical cells 
of high grade/poorly differentiated, advanced human carcinomas. Serial-section 
immunohistochemical (IHC) analysis and double immunofluorescent (IF) analysis 
showed co-expression of p21WAF1/Cip1 and the mitotic marker Ki67 in a subset of large 
cancer cells with giant nuclei in a) head and neck squamous cell carcinomas 
(HNSCC) (N=20), b) lung squamous cell carcinomas (N=30) (inset depicts a large 
atypical cell with p21WAF1/Cip1/Ki67 co-expression) and c) urothelial carcinomas 
(N=30). IHC and IF: Black and white thin arrows denote p21WAF1/Cip1 and Ki67 co-
expressing cells, respectively; IF: white and yellow thick arrows depict cells with 
mutual exclusive p21WAF1/Cip1 and Ki67 expression, respectively. Bars in IHC panels: 
50 µm, IF panels: 50 µm. 
 
Figure 2 Prolonged stimulation of p21WAF1/Cip1 in p53 null environment up-
regulates the Replication Licensing Factors (RLFs) at the protein level. a. Heat-
maps from the transcriptomic and proteomic analyses, at days 2 and 4, after 
p21WAF1/Cip1 induction in Saos2 p21WAF1/Cip1 Tet-ON cells. Set of significant genes that 
are overexpressed and underexpressed are shown, respectively. Schematic 
representation depicting significant genes that are up-regulated and down-regulated, 
along with their biochemical function, at day 4 upon p21WAF1/Cip1 induction in Saos2 
p21WAF1/Cip1 TetON cells. b. A specific p21WAF1/Cip1 mutant (p21PCNA: harboring Q144, 
M147, F150 substitutions to A in its PIP degron motif) abrogating its interaction with 
PCNA shifts CRL4CDT2-mediated degradation towards Cdt1. Lysates from Saos2 
cells, after transductions with corresponding retroviral-vectors, were separated by 
SDS-PAGE and immunoblotted to detect the indicated proteins. (Mock: pMSCV, 
p21WAF1: pMSCV-p21WAF1/Cip1, p21PCNA: pMSCV-p21PCNA) c. The status of p53 
defines the ability of p21WAF1/Cip1 to regulate the levels of Cdt1 and Cdc6. 
Immunoblots (IBs) for Cdt1 and Cdc6 in Li-Fraumeni fibloblasts, H1299 
p21WAF1/Cip1–Ponesterone-ON and HT1080 p21WAF1/Cip1–IPTG-ON cells challenged 
with p21WAF1/Cip1. Actin serves as a loading control. d. Flow cytometry analysis 
(FACS) of HT1080 p21WAF1/Cip1–IPTG-ON cells showed that induction of apoptosis 
as well as Cdt1 and Cdc6 expression are p53-dependent upon p21WAF1/Cip1 induction. 
Corresponding IBs for p53, Cdt1 and Cdc6 in the manipulated HT1080 p21WAF1/Cip1–
IPTG-ON cells. Actin serves as a loading control. e. FACS analysis of Saos2 
p21WAF1/Cip1 Tet-ON cells showed an accumulation of cells with >4N DNA content 
(re-replication) after p21WAF1/Cip1 induction that is Cdt1 and Cdc6 dependent. 
 
Figure 3. Sustained p21WAF1/Cip1 expression triggers replication stress and 
accumulation of DNA damage in a Cdt1/Cdc6-dependent manner in S-phase. a. 
Prolonged p21WAF1/Cip1 expression causes DNA damage. Lysates from Saos2 
p21WAF1/Cip1 TetON cell, after treatment with 1µg /ml Doxycycline for 96h, were 
separated by SDS-PAGE and immunoblotted to detect the indicated proteins and 
phosphorylation levels. To detect DNA double strand breaks, cells were collected and 
subjected to pulsed field gel electrophoresis (PFGEs). b. p21WAF1/Cip1 – dependent 
Cdc6 and Cdt1 overexpression produces DNA damage. Comet assays showed DNA 
breaks in cells induced for the indicated time points and after siRNA treatments 
against Cdc6, Cdt1 or both. Red lines in magnifications of insets label comet 
(moment) tails for length comparison. Bars: 50μm. c. p21WAF1/Cip1 expression, in cells 
with non-functional p53, activated the DDR pathway in a Cdc6 and Cdt1-dependent 
manner. Immunofluorescence and immunoblot analyses of the status of DNA damage 
response markers (53BP1, γH2AX) in p21WAF1/Cip1 induced cells for the 
corresponding time points and treated with siRNAs against Cdc6, Cdt1 or both. Bars: 
5μm, except in magnifications (circled or elipsoid shapes): 7.5 μm. d. Sustained 
p21WAF1/Cip1 expression reduced replication fork speed and affected replication fork 
symmetry. Saos2 p21WAF1/Cip1 Tet-ON non-induced cells versus induced ones for 96h 
and after 20min consecutive labeling pulses of CIdU (red) and IdU (green) were 
subjected to DNA fiber spreading analysis. e. Protracted p21WAF1/Cip1 expression 
inflicts DNA damage in S-phase. Flow cytometry analysis (FACS) of p21WAF1/Cip1 
induced cells for 96h and co-stained for γH2X/Propidium Iodide (PI), with or without 
anti-Cdc6/Cdt1 siRNA targeting, and p21WAF1/Cip1 induced cells for the indicated time 
points and co-stained for EdU/γH2X. 
 
Figure 4. Extended p21WAF1/Cip1 over-expression mediates replication 
intermediate lesions accumulation that are processed by MUS81-EME1 and 
repaired by a Rad52-dependent mechanism. a-b. Single-strand DNA (ssDNA) 
production in p21WAF1/Cip1 over-expressing cells. p21WAF1/Cip1 expression was induced 
for 96h with 1µg/ml Doxycycline. To detect ssDNA, cells were cultured in medium 
containing 10 µM BrdU for 24h, fixed and stained with antibodies against BrdU 
without DNA denaturation (a). Induced cells at 96h were also incubated with anti-
RPA antibody (b). c-d. p21WAF1/Cip1 mediated DNA damage is processed by MUS81 
resolvase. Comet assays showed DNA breaks in p21WAF1/Cip1 cells induced for 96h 
and after siRNA treatments against MUS81 (c). Red lines in magnifications of insets 
label comet (moment) tails for length comparison. Bars: 50μm. IB analysis depicts the 
efficiency of MUS81 siRNA treatment (c). Flow cytometry analysis (FACS) of 
p21WAF1 induced cells for 96h and co-stained for EdU/γH2X, with or without anti-
MUS81 siRNA targeting (d). e. Silencing of the homologous repair recombinase 
Rad51 resulted in decreased γ-H2AX levels. Lysates from Saos2 p21WAF1/Cip1 Tet-ON 
cell, after treatment with 1µg /ml Doxycycline for 96h, were separated by SDS-PAGE 
and immunoblotted to detect the indicated proteins and phosphorylation levels. f-g. 
Suppression of Rad52 was followed by increased γ-H2AX expression (f,g) and cell 
death (g). Lysates from Saos2 p21WAF1/Cip1 Tet-ON cell, after treatment with 1µg /ml 
Doxycycline for 96h, were separated by SDS-PAGE and immunoblotted to detect the 
indicated proteins and phosphorylation levels. FACS depicted increased γ-H2AX 
expression and cell death. h. Rad51 promoter is occupied by the E2F4 repressing 
transcriptional factor upon p21WAF1/Cip1 induction. Chromatin immunoprecipitation 
(ChIP) for E2F4 binding to the Rad51 promoter in non-induced and induced 
p21WAF1/Cip1 cells.  
 
Figure 5. Deregulated up-regulation of Cdc6 / Cdt1 links p53-independent 
activation of p21WAF1/Cip1 with senescence. a. Sustained p21WAF1/Cip1 expression 
triggers senescence. p21WAF1/Cip1 expression was induced for 96h with 1µg/ml 
doxycycline. Cells grown on coverslips were stained to assess the senescent 
phenotype applying the Sudan Black-B protocol (Georgakopoulou et al. 2013) and 
SA-b-gal (Dimri et al. 1995). Cells were treated with siRNAs against Cdc6, Cdt1, 
Cdc6/Cdt1 and p73. b. IBs depict p73 status upon siRNAs targeting Cdc6 and Cdt1, 
as well as the efficiency of anti-p73 treatment. c. Sustained p21WAF1/Cip1 expression 
reduces p14ARF and p16INK4A protein levels. Bars: 20 μm 
 
Figure 6. Prolonged p21WAF1/Cip1 expression, in cells with p53 loss of function, 
overrides the senescence barrier leading to aggressive behavior. a. Morphological 
features observed by reverse-phase contrast microscopy of escaped cells (20 days of 
p21WAF1/Cip1 expression). Bars: 15μm. b. BrdU incorporation is restored to almost 
similar levels to non-induced cells after bypass of senescence. Doxycyclin (1µg/ml) 
treated cells, up to 20 days, were cultured in medium complemented with 10 µM 
BrdU at 24h before collection, fixed and IF stained with antibodies against BrdU and 
p21WAF1/Cip1. c. EdU incorporation increases in p21WAF1/Cip1 expressing cells after 20 
days of continuous induction. FACS analysis of p21WAF1/Cip1 induced cells for 96h and 
20 days that were co-stained for EdU and p21WAF1/Cip1. d. Appearance of a significant 
sub-population of Cyclin A and p21WAF1/cip1 positive cells at 20 days of induction. 
Double IF analysis of induced cells for Cyclin A and p21WAF1/Cip1 at indicated time 
points. Bars: 50μm. e. Restoration of Cdk2 activity and reduction of p73 levels in 
cells “escaping” senescence (see also Supplemental Fig. S14). Cell lysates were 
separated by SDS-PAGE and immunoblotted to detect the indicated proteins and 
phosphorylation levels at 4 and 20 days of induction. f. Escaped cells depict larger 
nuclei than non-induced ones. Nuclei stained with DAPI. Histogram depicts average 
values in the two groups: OFF versus 20 days ON. Bars: 7.5μm. g. DNA damage was 
significantly reduced in escaped cells. Comet assays showed DNA breaks in cells 
induced for the indicated time points. Red lines in magnifications of insets label 
comet (moment) tails (TM) for length comparison. Bars: 50μm. h-i. Escaped Saos2 
p21WAF1/Cip1 TetON cells (45 days of p21WAF1/Cip1 expression) form more and larger 
colonies than the cells with non-induced (OFF) p21WAF1/Cip1 in soft agar assay (P < 
0.001) (h). They also exhibit increased invasion capability (i). j. Escaped cells (20d) 
exhibit increased genotoxic drug tolerance. Histogram depicting increased IC50 values 
by escaped cells upon treatment with Doxorubicin and Cis-platinum.  
 
Figure 7. p21WAF1/Cip1 expressing cells that have overridden (escaped) the 
senescence barrier demonstrate genomic instability. a. High resolution array-
Comparative Genomic Hybridization (array-CGH) analysis (Agilent G3 CGH 1M 
arrays) between “escaped” p21WAF1/Cip1 expressing cells and non-induced ones at the 
time point of 30 days. Gains and losses in the genome are depicted as blue and red 
colored regions along the chromosome ideograms, respectively (upper panel). 
Enlarged inset on left depicts two narrow subchromosomal areas exhibiting 
alternating regions of gains or losses with retention regions in between (highlighted in 
blue and red shadowed rectangles, respectively), that possibly indicate events of 
chromoanasynthesis and chromothrypsis, respectively. Along these areas there are 
large blocks of chromosomal losses located in the fragile site FRA3B. Inset on right 
denotes a representative result for a large scale subchromosomal loss. b. Prolonged 
p21WAF1/Cip1 expression leads to increase frequency of micronuclei in “escaped” cells. 
Arrows depict micronuclei. Histogram shows quantification of micronuclei in 
p21WAF1/Cip1 induced cells. c. Circos diagram depicting novel (N: 103) chromosomal 
rearrangements in “escaped” p21WAF1/Cip1 expressing cells revealed by deep 
sequencing (human chromosomes are located at the perimeter). d. Representative 
results showing the high correlation between the aCGH, deep sequencing (Next 
Generation Sequencing: NGS) and cytogenetic analyses results in “escaped” 
p21WAF1/Cip1 cells. e. Proposed model depicting prolonged p53-independent 
p21WAF1/Cip1 oncogenic action (see text for details). 
Supplemental Figure legends 
 
Suppl. Figure 1. p53-independent induction of p21WAF1/Cip1. Cell lysate of MCF7 
and MDA-MB-231 treated with TGF-β (5 ng/ml) for the time points indicated were 
immunobloted for p21WAF1 expression. GAPDH serves as loading control. 
 
Suppl. Figure 2. Timeline and bioinformatic algorithm employed in the analysis 
of the results obtained from the high-throughput transcriptome and proteome 
assay. a. Timeline of p21WAF1/Cip1 induction in Saos2 p21WAF1/Cip1 Tet-ON cells. b. 
Bioinformatic algorithm employed for the results obtained from the high-throughput 
transcriptome and proteome analyses at the indicated time points. Statistical analysis 
of the signaling outputs was followed by an adjusted Gene Set Enrichment analysis 
based on False Discovery Rate (FDR) correction. 
 
Suppl. Figure 3. Representative factors affected by p21WAF1/Cip1 induction at 
transcriptional and translational level. Representative real-time RT-PCR analyses 
to validate the high-throughput expression results (see also Fig. 2). a. Mitotic factors: 
PLK1, AURKB, BUB1, BUB1B, KIF23 and the pro-apoptotic factor GLIPR1 along 
with the suppressor of the p21WAF1/Cip1 mediated effects ID1 are transcriptionally 
downregulated at the indicated time points in Saos2 p21WAF1/Cip1 Tet-ON induced 
cells. Growth factor IGFBP5, the ion channel encoding gene TRPM8 and the poly-A 
binding protein PABPC1L are upregulated. PBGD: Porphobilinogen deaminase 
(house-keeping gene) b. Representative immunoblots that validate the proteome. 
Actin serves as a loading control. (PLK1: Polo-like kinase-1; AURKB:  Aurora kinase 
B; BUB1: budding uninhibited by benzimidazoles 1 homolog; KIF23:  kinesin family 
member 23; GLIPR1: Glioma pathogenesis related 1; ID1: inhibitor of DNA binding 
1; IGFBP5: insulin-like growth factor binding protein 5; TRPM8: transient receptor 
potential cation channel subfamily M member 8; PABPC1L: poly(A) binding protein, 
cytoplasmic 1-like; TOP2A: topoisomerase 2A) 
 
Suppl. Figure 4. Timeline of senescence appearance in Saos2 p21WAF1/Cip1 Tet-ON 
induced cells. Activation of the senescence barrier occurs at day 3 of induction in  
Saos2 p21WAF1/Cip1 Tet-ON cells and increases gradually, reaching its highest value at 
day10, while no signs of senescence are evident in untreated cells (as corresponding 
graphs depict). p21WAF1/Cip1 was confirmed by western blot (upper right panel). Actin 
served as a loading control. 
 
Suppl. Figure 5. Potential mechanisms leading to increased Cdc6 and Cdt1 
protein abundance upon sustained p21WAF1/Cip1 expression. a. Cdt1 stabilization 
via saturation of CRL4CDT2 and SCFSkp2 ubiquitin ligase complexes due to 
overabundance of p21WAF1/Cip1 (see text for details). Lysates from Saos2 p21WAF1/Cip1 
Tet-ON cell, after treatment with 1µg /ml Doxycycline for the depicted time points, 
were separated by SDS-PAGE and immunoblotted to detect the indicated proteins. b. 
Cdt1 and Cdc6 reduced turnover due to the cell cycle profile imposed by constitutive 
p21WAF1/Cip1 expression. Flow cytometry analysis (FACS) to assess DNA content 
(Propidium iodide) was performed at the indicated time points. c. Stabilization of 
Cdc6 by p21WAF1/Cip1 over-expression. p21WAF1/Cip1 expression was induced for 96h 
with 1µg/ml doxycycline. Cells were treated with 100µg/ml cycloheximide (CHX) 
and 10µM MG132 for the indicated time points and depicted proteins and 
phosphorylation levels were analyzed by immunoblotting. Actin serves as loading 
control. d. Real-time RT-PCR assessment of Cdh1/Fzr1 in induced and non-induced 
Saos2 p21WAF1/Cip1 TetON cells. GAPDH served as a normalizing housekeeping gene.  
 
Suppl. Figure 6. E2F1 is upregulated while Chk1 is activated upon prolonged 
p21WAF1/Cip1 induction. Lysates from Saos2 p21WAF1/Cip1 Tet-ON cell, after treatment 
with 1µg /ml Doxycycline for the depicted time points, were separated by SDS-PAGE 
and immunoblotted to detect the indicated proteins. Actin serves as a loading control.  
 
Suppl. Figure 7. A decline of Cdk2 activity is observed following p21WAF1/Cip1 
induction. Histogram depicting decreased Cdk2 activity at days 4 after p21WAF1/Cip1 
induction. 
 
Suppl. Figure 8. MCM2-7 chromatin loading is increased following p21WAF1/Cip1 
induction. a. Diagram describing cell fractionation experimental algorithm. b. All 
fractions were separated by SDS-PAGE and were analyzed by IB. Lamin-B served as 
fractionation control, while β-tubulin as loading control. c. FACS analysis of MCM2 
chromatin loading in induced Saos2 p21WAF1/Cip1 Tet-ON cells versus non-induced (-
ve: control experiment with no MCM2 antibody; +ve: experiment with MCM2 
antibody). 
 
Suppl. Figure 9. Re-replication and DNA damage was significantly lesser in 
Saos2 cells infected with p21PCNA mutant. a. Comet assays showed DNA breaks in 
cells infected with the indicated constructs (see also Fig. 2b). Red lines in 
magnifications of insets label comet (moment) tails for length comparison. b. FACS 
analysis of the corresponding treatments. (p21PCNA: mutant p21WAF1/Cip1 harboring 
Q144, M147, F150 substitutions to A in its PIP degron motif) 
 
Suppl. Figure 10. PCNA staining patterns reveal that sustained p21WAF1/Cip1 
expression, in cells with non-functional p53, “traps” cells mainly in early S-
phase. IF analysis for assessing PCNA staining patterns in non-induced and 96h 
induced cells. Histograms depict average of observed patterns in the induction 
conditions employed. Bars: 10 µm.   
 
Suppl. Figure 11. Replication intermediate lesions harboring single stranded 
DNA (ssDNA). a. Uncoupling of the replicative helicase and polymerases results in 
generation of template ssDNA due to excessive unwinding of the template (stalled 
fork). b. Deregulated firing of clustered origins leads to replication stress and 
accumulation of gaps in the nascent strands, leaving template ssDNA. c. A stalled 
replication fork may undergo remodeling by creation of a Holliday junction-like 
structure termed “chicken foot”: i) Direct CtIP processing of a reversed fork may lead 
to nascent strand ssDNA formation. ii) Cleavage by SLX4-docking nucleases 
generates DNA double strand break that is subsequently followed by resection 
resulting into nascent strand ssDNA generation. d. Unequal branch migration or 
resection (by CtIP) of a reversed fork can also lead to generation of template ssDNA. 
 Suppl. Figure 12. Absence of nascent ssDNA in p21WAF1/Cip1 expressing cells. 
p21WAF1/Cip1 expression was induced for 96h with 1µg/ml doxycycline. The newly 
synthesized DNA was labeled for 20 min with 10 µM BrdU. 2 mM HU and 5 µM 
ATRi were added after the BrdU pulse as indicated for 2 h. After the indicated 
treatments, cells were fixed and stained with antibodies against BrdU without DNA 
denaturation to selectively detect nascent-strand ssDNA. 
 
Suppl. Figure 13. P21WAF1/Cip1 mediated DNA damage is processed by MUS81 
resolvase. IF staining of DDR markers (53BP1 and γH2AX) in p21WAF1 induced cells 
for 96h, with or without anti-MUS81 siRNA targeting. Histogram depicts 
quantification of 53BP1 and γH2AX foci/cell. Bars: 10μm.  
 
Suppl. Figure 14. Sustained expression of p21WAF1/Cip1 in cells with non-
functional p53 leads to restoration of Cdk2 activity in “escaped” cells. Following 
an initial decline (days 2-12) Cdk2 activity is increased in “escaped” cells (after day 
20). 
 
Suppl. Figure 15. Continuous p21WAF1/Cip1 expression affects nuclei area of 
escaped cells. Escaped (20 days) p21WAF1/Cip1 induced cells exhibit increased nuclear 
area.  
 
Suppl. Figure 16. “Escaped” Saos2 p21WAF1/Cip1 cells exhibit increased genomic 
instability relative to non-induced cells. a. Timeline of experimental planning of 
genomic analyses. b. Overview of all array-CGH (aCGH) analyses results. In total 41 
aberrations were found involving all chromosomes (except 9, 12, 14 and 15). The 
aberrations included 19 gains and 22 losses (Supplemental Table 5). The majority of 
aberrations were concentrated in chromosomes 3, 10 and X (Supplemental Table 5). 
[reference (Ref) genome is from un-induced (0 d) Saos2 p21WAF1/Cip1 cells] c. Novel 
clonal rearrangements distinguish the “escaped” Saos2 p21WAF1/Cip1 (ON) from OFF 
cells [arrows indicate lost (in OFF cells) or rearranged (in “escaped”-ON cells) 
chromosomes]. The p21WAF1/Cip1-OFF cells (control), were mainly hypotriploid (51-56 
chromosomes) and shared most of the characteristic structural chromosome 
aberrations of the parental Saos2 cell line (Sakellariou et al. 2013). Compared to 
these cells, the “escaped” ones remained hypo-triploid but displayed at least 10 novel 
clonal structural or numerical aberrations affecting chromosomes 2, 3, 5, 8, 11, 13, 14, 
20, 21 and X. Large portions of chromosomes X and 13 were lost in 90% of the 
“escaped” cells, confirming the aCGH findings. Furthermore, differential imbalances 
of chromosomes 5 and X between Saos2 p21WAF1/Cip1 ON cells and the controls were 
observed. In “escaped” (ON) cells, an additional inverted duplication of 5p was also 
present in 90% of the examined nuclei. d. The Saos2 p21WAF1/Cip1 ON cells exert 
significantly higher rates (two fold) of random structural CIN/chromosome as 
compared to controls. (CIN:chromosomal instability) e. Genomic distribution of 
breakpoints of random structural chromosome anomalies. Telomeric regions were 
found to be most frequently affected by fusions, translocations and tandem 
duplications of large chromosome segments. As unidentified ones were categorized 
the non-telomeric, non centromeric genomic rearrangements in which the cytogenetic 
bands of their breakpoints remained obscure.  f. “Escaped” Saos2 p21WAF1/Cip1 cells 
exhibit increased karyotypic aberrations relative to non-induced cells. Comparative 
pseudo-colored M-FISH/SKY karyograms of 10 non-induced (OFF) Saos2 
p21WAF1/Cip1 cells (588 chromosomes) and 10 “escaped” (ON) ones (639 
chromosomes), for the evaluation of whole genome structural CIN at the 350 
chromosome band level. Arrows (and dashed rectangles) indicate representative non-
clonal random structural rearrangements (unique anomalies encountered in a single 
cell). The “escaped” p21WAF1/Cip1 expressing cells (ON) displayed significantly higher 
rates of genome wide, random structural chromosomal rearrangements. ON cells 
(upper panel): Cells #1 and #7, from the Saos2 p21WAF1/Cip1 OFF panel, represent a 
minor subclone (20%) of this population because they share a distinctive clonal 
rearrangement affecting a derivative chromosome X and a deletion of 12p. Cells #3 
and #5, belong to a second subclone of the control cells that is characterized by a 
deletion of a rearranged chromosome 19. The remaining non-induced (OFF) 
p21WAF1/Cip1 cells #2, #4, #6, #8 and #10, display a homogeneous karyotypic 
constitution and represent the major clone. Cell #9 is a polyploid product of whole 
genome endoreduplication of the major clone of Saos2 p21WAF1/Cip1 OFF cells. 
“Escaped”-OFF cells (lower panel): Cells #1 and #6 differ from the majority of the 
“escaped” (ON) population as they share a clonal inverted duplication of the long arm 
of chromosome 21. In addition, cells #2, #4 and #9, have lost a marker translocation 
der(9)t(5;9) that was replaced by a deletion 9p and acquired clonally an extra 
translocated der(22)t(20;22). A unique subclonal finding in Cells #3 and #10, of the 
“escaped” (ON) cells is the persistence of der(9)t(5;9). Cells #5 and #7 represent two 
different endoreduplicated ON subclones, characterized by unique structural 
abnormalities of chromosomes 7, 15 and 6 respectively. The karyotypic constitution 
of cell #8, resembles that of the control population and justifies the presence of an 
additional subclone that does not exceed the 10% of the “escaped” (ON) cells. 
(CIN:chromosomal instability)  
 
Suppl. Figure 17. Correlation between aCGH replicates and corroboration with 
the cytogenetically detectable novel clonal alterations (* see also Supplemental 
Fig. S16c). [reference (Ref) genome is from un-induced (0 d) Saos2 p21WAF1/Cip1 
cells] 
 
Suppl. Figure 18. Correlation between aCGH and deep sequencing (Next 
Generation Sequencing: NGS) analyses. 
 
Suppl. Figure 19. Differentially expressed genes whose expression status affects 
cancer according to literature. Expression status of genes associated with cancer 
progression. a. Timeline of experimental planning of transcriptome analyses. b. 
Principal Component Analysis (PCA) of the differentially expressed genes depicting 
the majorly different gene expression signatures over 285,000 transcripts analysed. c. 
Heat maps of differentially expressed genes. d. Relative expression levels given as 
log-2-ratios of differentially expressed genes (p < 0.05) of the “escaped” vs OFF-
cells, whose expression status (up or down-regulated) is reported to promote 
carcinogenesis. e. Differentially expressed genes whose expression status either 
promotes or suppresses cancer according to literature. Relative expression levels 
given as log-2-ratios of differentially expressed genes (p < 0.05) of the “escaped” vs 
OFF-cells. The lengths of the “encircled” lines depict the intensity of expression.  
 
Suppl. Figure 20. Validation of representative factors in “escaped” (ON) cells 
versus non-induced (OFF) cells. Representative real-time RT-PCR analyses, 
validating the high-throughput expression analysis (see also Fig. 8). 
 
Suppl. Figure 21. Relative gene expression levels (log-2 ratios) at 12, 48, 96-hs 
after p21WAF1/Cip1 -induction as well as “escaped” versus OFF cells. a. Relative 
expression of all measured genes (19540) at each depicted time-point as compared to 
non-induced cells (OFF). The correlogram at the bottom which presents the Pearson 
correlation coefficient among the 4 datasets illustrates that the overall gene-expression 
of the “escape” population is non-correlated (~0 correlation coefficient) to the three 
prior time points, which amongst them present a high degree of correlation. b. 
Relative expression of genes presenting differential expression (p < 0.05) in the 
“escaped” cells in relation to OFF (553 genes). The correlogram at the bottom 
illustrates the absence of correlation between the “escaped” population with the three 
early time points (12, 48, 96hs). c. Relative expression of commonly differentially 
expressed genes (42) (p < 0.05) at each time-point versus OFF. Special interest 
present the 16 out of 42 marked genes whose expression levels are reversed at the 
“escape” population in comparison to the previous time-points. 
 
 
